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Biography
Dr. Ross Hays is the director of the Seattle Children’s Hospital Palliative Care Service,
the chair of the Ethics Committee, and a professor in the Department of Pediatrics.
Dr. Hays trained at the University of Washington for his M.D., completed residencies in
pediatrics, physical medicine and rehabilitation medicine, and a fellowship in birth
defects. Dr. Hays has authored over 80 peer reviewed articles and abstracts, over 20 book
chapters, has spoken at over 70 conferences domestically and internationally.
Interview Abstract
Dr. Ross Hays begins the interview by describing how he continued to pursue training
after his pediatrics residency, transitioning to study birth defects, training in rehabilitation
medicine, and finally training in bioethics. Dr. Hays was then recruited to become the
principal investigator for a demonstration project by the Robert Wood Johnson
Foundation titled Promoting Excellence in End-of-Life which finally allowed him to tie
all his training experiences together.
Dr. Hays then describes his observations that pain in pediatrics was recognized, but there
was a lack of urgency in clinical need to treat pain—maybe in part due to that lack of
sophistication in treatment paths for pain in the early 1980s. He also recalls that
psychological and social support of pediatric patients and families were not typically seen
as a necessary duty to fulfill by the medical community and largely became the
responsibility of the family.
The differences between primary and specialty palliative care are also defined by Dr.
Hays as he describes how other hospital services met his palliative team with some
suspicion and anxiety of his palliative service overstepping and usurping turf. He also
explains that there will always be a need for palliative care due to the progression of
medicine and more complex therapies available. When someone elects to complete these
more complex therapies, they create the need for palliative care along their health care
journey.
Dr. Hays describes the most looming challenge for palliative services to be funding,
especially outside of wealthy institutions that can support a palliative service that
generally is not reimbursed well. Dr. Hays also describes that the best thing about the
palliative field now is the new generation of well-trained leaders that are stepping up to
take the lead.
The interview concludes with Dr. Hays’ dream of having palliative services fully
integrated and automatically consulted on every case of a leukemia or complex
congenital heart disease or when a child goes on ECMO. He would like to see that
palliative care professionals become viewed as integral parts of the medical team.

Interviewer: Bryan Sisk
Interviewee: Ross Hays

Glossary of Acronyms
Abbreviation Definition
CAR T-Cell Chimeric Antigen Receptor T (Tlymphocytes) Cell Therapy
ECMO Extracorporeal membrane
oxygenation
Heme/onc Hematology/oncology
ICU Intensive care unit
IPPC Initiative on Pediatric Palliative Care
NICU Neonatal intensive care unit
PI Principal investigator
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Today is September 3, 2019. I am Bryan Sisk. I am in St. Louis,
Missouri interviewing Dr. Ross Hays for the Pediatric Palliative
Care Oral History Project. Dr. Hays is in Seattle, Washington.
Thank you, Dr. Hays, for joining me today, to get us started could
you just tell me when you mind turned toward pediatric palliative
care as a career focus?
I believe it was around 1997 when my organization, Seattle
Children's Hospital, was interested in competing for an award
through the Robert Wood Johnson Foundation Promoting
Excellence in End-of-Life Program. These were demonstration
projects that were going to be funded by The Robert Wood Johnson
Foundation and a group at people at Seattle Children's drafted me to
be the principal investigator on that project. I think that as a career
focus, I suppose, that's where it started. I'll say that earlier on—I
have additional training in bioethics. Around 1991 as part of a
bioethics effort, was exposed to Elizabeth Latimer when she came
to Seattle to give a lecture. She was the first person I really heard
talk about palliative care as a clinical service. That was much earlier,
that was maybe, around 1991.
You have an interesting background where you studied pediatrics
and then birth defects and then did physical and rehabilitation
medicine training. How did all that fit into your career before ethics
and palliative care came more of the forefront?
Good question. It doesn't appear to be a logical connection, but in
doing pediatrics and rehabilitation medicine, one of the areas where
I gravitated and eventually specialized was in progressive
neuromuscular disease. My clinical focus was children with spinal
muscular atrophy and muscular dystrophy. In the late-80s to early
90s, or even before that, in the 80s I should say, the majority of those
patients died at a young age. Spinal muscular atrophy. Type I
patients usually didn't live through their first birthday, Duchenne
patients didn't usually live to be 20, and so providing comprehensive
care for them included some aspect of palliative care, even though
we really didn't call it that. So that was my clinical focus. I had a
very thoughtful chairman who first recognized in me that I had this
interest in the larger view of this population. One time he told me,
he said, "You agonize over these children. I think you need to learn
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how to agonize more constructively." He introduced me to Al
Johnson, who was the Chair of the Department of Bioethics and
Humanities here at Seattle Children's, and that's when I started my
bioethics training. The bioethics training and the experience in
caring for children with serious life ending illness that I got through
my rehab clinical work really was the clinical foundation for moving
ahead with palliative care.
[00:04:51]
Bryan Sisk:

Ross Hays:

[00:06:32]
Bryan Sisk:

Ross Hays:

Before you were volun-told that you were going to be the PI
[principal investigator] for this Robert Wood Johnson Foundation
End-of-Life Excellence program, before that, had you already
established in your own mind that, "I'm really interested in and
going to focus on the suffering in this end of life care," or was it that
you had an interest but it didn't become as apparent until you
volunteered for that?
No, I think I had an interest before that. As I mentioned I was
exposed to the concept of palliative care in general much earlier than
that. I was also doing clinical work at the University of Washington
Pain Center, where I was involved in pain and symptom
management, before, primarily patients with chronic pain. I did that
for eight years and I started that in 1993, and so, began to develop
some of the fundamentals of understanding how to do pain and
symptom management in that setting. I also had a chance there to
meet another physician, Stu Farber who was then a Project On
Death in America PDIA Fellow. That was a program started through
the Soros Foundation. I think I got a healthy exposure to the field
earlier on through Stu and through my opportunity to work with pain
patients.
When you were starting out, let's say when you got to the late-90s
and you were starting to PI this End-of-Life Excellence project, did
you find a community of similar minds at that time?
Yeah, as I said I was sort of drafted for this project, and there were
two nurses who became the managers of the project and were very
committed to this. Other names were Mo Palmetto and Gerri
Haynes. And Gerri Haynes in particularly had a lot of experience.
She had as a hospice nurse, worked on the development of a freestanding hospice facility here in the Seattle area, and was very, very
familiar and committed to that. She then was part of—she and Mo
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Palmetto together were funded by an organ of our hospital, which
was then called The Office of Children with Special Health Care
Needs. As part of that, they did a statewide assessment of pediatric
death in Washington State. They spent two years gathering data
about how many children die in our state, what their most common
diagnoses are, place of death, and then followed that up with a
qualitative study where they interviewed bereaved families to find
out what their needs were and that was sponsored by this Center for
Children's Special Health Care Needs. They were very much
committed to the idea of improving end-of-life care for children and
became my closets colleagues.
[00:08:45]
Bryan Sisk:

Ross Hays:

[00:10:03]
Bryan Sisk:

Ross Hays:

Sounds like Seattle was really ahead of the times at that point. Did
you have a lot of colleagues at other institutions who had similar
experiences?
No, if you've been talking to some of the people, some of the leaders
here, some of the leaders of our field, like Joanne Wolfe and Chris
Feudtner. Chris Feudtner actually at that time was a Robert Wood
Johnson scholar here in Seattle. He had done his pediatric residency
here and went on to get an MPH through the program that's no
longer available. But when Chris was here at Seattle at that time and
got similarly drafted into this project. We worked together, we
actually applied for PDIA fellowships together and didn't get one,
but we worked on a number of other things. And then, as you know,
he went on to Children's of Philadelphia and has established quite
an important new national reputation as a palliative care specialist.
Who did you learn from as you were focusing on end-of-life and
what would become palliative care?
[laughs] I think we kind of, had to all teach each other. In the
beginning I think it was a matter of going to what we had in the
literature and then our shared experience. I think in the beginning it
was really an opportunity to be on auto didact. I mean we had to
learn from each other. The American Academy of Hospice and
Palliative Medicine was a very tiny organization then, and we would
go to their meetings and you would gather information from that
and, from wherever. Also being part of that larger Robert Wood
Johnson Promoting Excellence and End-of-Life Care program, that
program sponsored end-of-life opportunities for all of us to get
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together. At least twice a year they would bring all of the PIs together
and we would compare notes and we would learn from each other
and so, there were opportunities like that. There was also, right
around the 2000 or so, there was effort around called the Initiative
on Pediatric Palliative Care, the I-P-P-C. They were doing a lot to
educate people particularly about pediatric palliative care. I
remember, I think it was in the spring of 2004, they sponsored a
conference where they brought people who were doing this. I don't
know if you could say leaders in the field, but people who were
doing this altogether at a big conference in Massachusetts where we
had an opportunity to kind of, learn from each other. There were a
couple of organizations out there that were leading the way in terms
of providing the beginnings of an academic foundation for the field.
[00:12:31]
Bryan Sisk:

Ross Hays:
[00:12:56]
Bryan Sisk:

Ross Hays:

[00:14:46]

I just want to take a second to go back a little further. You had
finished medical school in '78 and then started your residency
program at Brown I believe, after that. Around that time when you
just beginning your clinical work, what were the biggest challenges
that you observed caring for suffering and seriously ill and dying
children?
When I was a trainee at Brown?
Just back around the late 70s or early 80s when you were first getting
into this, what do you recall as challenges in caring for these kids at
that time?
That's a really good question. I think hematology oncology probably
had made some headways in understanding the language of the
hospice and palliative care for children, but it was relatively
primitive then. Death in childhood is pretty unusual and the Brown
program was really a generalist training program, so where we
would encounter end-of-life would be in heme/onc [hematology
oncology] and in the NICU [Neonatal intensive care unit] and rarely
elsewhere. There wasn't a lot of sophistication in understanding
things like incorporating family preferences into end-of-life care or
understanding end-of-life care as a concept by itself. I think that
those were really nascent at that time. I mean there was a lot of room
to improve on the situation as it was back then.
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Bryan Sisk:

What about pain in children? How effectively was pain managed
earlier on?

Ross Hays:

Variably, I think. Probably not well and probably not nearly as well
as it is now. Again, that was quite a long time ago and so there
weren't as many choices in pain management as we have now. I think
that people didn't really recognize the importance of managing pain
and symptoms as much as we do. There wasn't much of an emphasis
on it then as there is now. I don't think that we were doing
particularly well. Joanne Wolfe published a paper in 2000. It said
that although all children with cancer who died in their institution
who treated for pain, only 50% of them felt like they've been
effectively treated for pain, and that 80% of them had experienced
suffering in the last few weeks of their lives. I don't think we were
doing as good a job. I think it was we didn't know what questions to
ask. I think we weren't educated. We were afraid of opioids. There
were just a lot of reasons why we didn't do a better job.

[00:16:24]
Bryan Sisk:

Ross Hays:

[00:17:55]
Bryan Sisk:

What about psychological and social needs, did those receive a lot
of attention in pediatrics in the early 80s in your experience?
I don't think they did universally. I don't think it was really
recognized as part of what the medical community needed to offer.
I think there were families that were very resourceful and found their
resources and did a remarkable job. Then I think there were other
families who didn't have those resources and didn't know where to
look and didn't have a lot of help from the medical side, and so I
think they probably suffered a fair amount. I think in those early
stages, whether you got good social, psychological, spiritual support
really was dependent on how resourceful the family was. It really
wasn't seen as a responsibility of the medical team. I think it was
much more the medical side was tasked with doing the best they
could to treat the disease, but the larger picture of the whole human
experience of end-of-life wasn't really—I don't think it was really
understood to be a medical responsibility.
Following up on that, did clinicians at that time have an awareness
or you have the terminology of suffering when thinking about kids?
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Ross Hays:
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I don't think anybody missed the fact that children were suffering. I
think the medical providers were suffering too, it's just that I don't
think we had the tools to be more constructive about it.
You said earlier agonize more constructively.
[laughs] Yeah, that was my chairman. He was very insightful.
I also wanted follow-up on that, agonizing more constructively led
you to bioethics. I am interested, has your continued role in bioethics
and your role in palliative care, have those complimented each other
or have they led to any tension?
I think they're more complimentary than they are in opposition to
each other. I think there are many, many bioethical questions that
come up in end-of-life care, so having some facility with both I think
is a helpful thing. I do think that if you're being a provider who is
participating in both, so that would be like bioethics consultation
and palliative care consultation, I think there is an important part
about keeping those two separate. The big difference for me is in
bioethics consultation, you want be as objective as you can be and
often you're called to be a third-party observer in clinical disputes or
in an ethical question where there might be one or two different
factions or sides that are trying to influence a solution. And so
objectivity is very important in bioethics consultation.
In palliative care consultation, it's sort of the opposite. I mean very
often we find ourselves being advocates for the family, the patient
and the family. And sometimes we have to insert ourselves into the
clinical conversation to be sure that families have clear information
and understanding about the choices that they're making and the
decisions that they face and that in situations where there may be a
bias that's inherent in the clinical treatment, that the families
understand that they still have final authority to consent or not to
treatment or to change the course of treatment. In my experience in
palliative care consultation you forfeit your objectivity
appropriately so that you can be a more effective advocate for the
patient and family. So answering your question, I think the two of
them work together. I think bioethics informs palliative care,
palliative care provides a lot of clinical material for bioethics and so
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they go together in that way. But when you're actually doing clinical
consultation there are important reasons to keep them separate.
[00:22:01]
Bryan Sisk:

Ross Hays:

[00:23:43]
Bryan Sisk:

Ross Hays:

How did your clinical career develop? You started in rehab medicine
and then you started in with more and more ethics, so did you
continue doing rehab medicine overtime? How did that all progress?
Pediatric disability or pediatric rehabilitation is the job that I was
hired to do, so I continued to do that. But as the palliative care
service began to increase, I did have the flexibility to gradually
increase my palliative care clinical work and gradually decrease my
pediatric rehab work. That was a luxury that was provided to me by
my very generous institution, Seattle Children's Hospital—have the
ability to give me that flexibility, and so it was a very gradual
progression. I'll tell you that I only disengaged completely from the
pediatric rehab department a month ago, or 2 months ago in July, so
I continued do participate in that Department primarily as an
outpatient clinic provider until this summer.
What do you think were the biggest challenges you faced as you
started developing this pediatric palliative care niche?
I think in the beginning it was establishing the legitimacy of what
we did. I think that when you have new service that adds value to a
system that already exists, then sometimes you have to state your
case; you have to prove that what you're doing adds value. So for
example, in the course of caring for pediatric cancer patients, the
heme/onc providers who provide the clinical treatment for cancer
would feel that they were not only experts at providing cancer
treatment, but they were also experts at providing end-of-life care
for their patients if they're treatment didn't work. And so they
already had that role and identified with it. Then when you come in
and say, "We're going to provide palliative care," it would be very
natural for the hematology oncology providers to say, "We're already
done that. We don't need you. You're not necessary here." And if
from our point of view, what we had to offer was a way to do it
better, you have to be very careful about how you promote that.
Because it's very easy for someone who's been involved in that
aspect of care for a long time to look at any offer of additional help
that would be an improvement as a statement on what they are
already doing, if you understand what I'm trying to say. By saying,

Interviewer: Bryan Sisk
Interviewee: Ross Hays

September 3, 2019
Page 12 of 20

"Oh, yes we have palliative care. We believe that we could add value
to end-of-life," it could be interpreted by those who are already
providing that care as well, "You're saying that we're not doing it
well enough," and that puts people on the defensive. We often
experienced that I would say to some degree from physicians, but
really very strongly from our colleagues in social work. They really
were often not appreciative of us trying to add on to what they were
already doing. It was interpreted as a statement that what they were
doing wasn't good enough. And we never, ever intended it to be that
way of course, and it wasn't that way, but there is that possibility of
interpreting that way. To answer the question, I think it was our
biggest barrier. I think we just had to continue to do the work and to
believe in the value in what we were doing and let the work speak
for itself and eventually that resistance went away.
[00:27:36]
Bryan Sisk:

Ross Hays:

What were your best practices, looking back the best things you did,
that allowed you to get beyond that resistance?
Sometimes it was always being supportive. If we got a request to
meet with the patient and the family, we would always be diplomatic
and explain to the referring team why we were there and what we
were doing, and be very intentional about the fact that we were
partnering with them and then we had no interest in competing for
the family’s affections or trying to move the patient over to our own
service and to interfere in any way to the relationships that had
already been developed between the patient and the family and their
providers. We always, always would bend over backwards to be
cooperative and to be as open as and to communicate as effectively
as we possibly could with the referring service. It's funny Joanne
Wolfe used to say that, "50% of pediatric palliative care is
diplomacy." And I really believe that, that is still true for us. I mean
we are very respectful of the services their request us, whether it is
in the ICU [intensive care unit], the neural muscular disease service,
the hem/onc service, or bone marrow transplant team, whatever;
very, very respectful of the fact that they asked us to come in and
very reluctant to do anything that looked like it would interfere with
that relationship. So I truly believe that 50% of pediatric palliative
care is diplomacy. I was at a meeting Joanne and we were talking
and I quoted that, and she said, "No, that's not right." I said, "Well
Joanne how can you tell me that's not right? I learned that from
you." And she said, "it's because it's 80%." And I thought, "Okay."
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[laughs] That is the way you have to do it. Often I felt what we were
doing is enter into a situation, we'd recognize there was some
deficiency there, maybe the pain wasn't being managed adequately
or maybe the family was in the dark about some critical decision or
the communication between the medical team and the family had
not been thorough. We'd recognize something to be addressed and
sometimes the best way to that was to find a way to put that idea in
the head of the person who asked us to get involved. If it was the
ICU attending who we recognized wasn't really communicating
with the family and the family was not really getting what they
needed, we would find a way to make that attending aware of the
fact that she needed to do more in some kind of subtle way and then
watch her do it and then congratulate her for being so thoughtful and
being so proactive. And that was often the way you would make
progress for patients and families. And it requires a certain amount
of humility because you could just never take credit for what your
work was, because you had to make it look like it belonged to
somebody else.
[00:31:38]
Bryan Sisk:
Ross Hays:

Has that changed overtime or is that still the same?
I think there is still an element of that. But you know there's this
newer concept now that I think really came from Timothy Quill
about specialty palliative care and primary palliative care. Specialty
palliative care is what we're trained to do—it's more complicated
pain and symptom management and it's a more aggressive way of
recognizing ways to improve communication and provide
continuity. I mean those are the things that a palliative care
fellowship trains you to do, and so that's specialty palliative care.
Primary palliative care is basically the attitude of creating an
environment that promotes better care at the end-of-life. So it is
improved communication, it is a basic understanding of pain and
symptom management, and it's something that everybody, every
provider should have, and I know you're aware of this. I think what's
happened over the last decade and so is that, there's been this
development of specialty palliative care as a specialty, but there's
been I think great improvements in the whole concept of primary
palliative care too. I think the quality of care in both aspects
specialty and primary palliative care has risen overtime and so. I
think there are more people who are more thoughtful about the way
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they are treating patients at the end of life and so, I think that our job
is not quite as obvious as it was 20 years ago.
[00:33:38]
Bryan Sisk:

Ross Hays:

Looking more globally from your perspective, what do you think
was the spark that really drove the development of pediatric
palliative care as a specialty?
I think that palliative care in general, I mean I think we got to the
point in the 90s where I think the whole medical community, really
led by the Soros Foundation and the Robert Johnson Foundation,
began to look at the way we managed end-of-life care and
collectively said, "We suck at this." And that's when, particularly
those two agencies, but others got on board and said, "We need to
take this on. We need to make improvements here." And so that was
in the early to mid-1990s, that was American health care in general.
And we didn't have to look to far to find better systems. I think
Canada was already ahead of us. I think the U.K. was ahead of us in
terms of more enlightened hospice care and more attention to endof-life care. So that happened in the early to mid-90s, palliative care
in general.
I think in pediatric palliative care there were a few pioneers really
who took this on and led the way. People like Pam Hinds in
Washington D.C. and Joanne Wolfe certainly, but others; Ann
Goldman in the U.K. It was individual people who recognized there
was a need for this and I think because it was mostly in academic
centers, not only did they initiate the clinical service, but they
initiated an academic approach to it with research and education as
being a component of the specialty from the very beginning. I think
that's what happens when you have a brand new specialty that
develops at this day and age. We know enough now to realize that
you just can't go out and do the clinical work; you have to provide I
think the academic justification for it at the same time, and so very
thoughtful people did that. Bruce Himelstein was another person
who took this on very early on. He's not doing it anymore now, but
there were people, individuals I think, who were largely responsible
for getting this off the ground.

[00:36:29]
Bryan Sisk:

You had mentioned the Robert Wood Foundation and the Soros
Foundation, how important were these funders in the development
of pediatric palliative care?
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Well I think they were very important legitimizing palliative care in
general, not so much pediatric palliative care. Robert Wood Johnson
Foundation Promoting Excellence in End-of-Life Care, they had
like 760 letters of intent from different organizations wanting to do
a demonstration project and they chose 22 to fund. Each one of them
was funded for three years and of those 22, only two were pediatric,
so that was here at Seattle's Children's and at Cardinal Glennon
Hospital in St. Louis. I think those agencies were very important in
the development of palliative care in general, and hospice too and
actually, I think in broadening the view of hospice. But I think
pediatric palliative care wasn't the target of those agencies and it
shouldn't have been. I mean when you think about it, pediatric
palliative care is a tiny, tiny subset of palliative care in general.
When do people die? They die when they're old, and so palliative
care in general is quite big, but pediatric is a really small subset, it's
a very intensely different subset. We're small compared to palliative
care in general.
And thinking more about palliative care in adult hospice, how much
do you think the adult hospice movement affected the development
of pediatric palliative care?
I think minimally. They had enough on their plates already trying to
improve care for adults at the end-of-life, which is again, that is the
industry. I think it was a few enlightened individuals who really
emphasized pediatric hospice care. We here in Seattle were lucky
there was a visionary person in our hospice community here who
recognized that there needed to be a dedicated pediatric hospice
program and she really made the case and found a willing sponsor
and developed a dedicated community-based pediatric palliative
care and hospice program. And so, we've had that here in Seattle for
probably 15 years or so, but that's not the case everywhere else. I
mean even in large Metropolitan areas, like in Boston, Philadelphia
and New York, there aren't dedicated pediatric hospice programs.
There are hospices that provide care to children occasionally and it's
a continual issue for them because those hospices who have nurses
primarily who are familiar with adult hospice and very comfortable
doing that, don't feel very comfortable taking care of children, and
so, they really rely on organizations like the palliative care programs
at Children's of Philadelphia or Boston Children's or Seattle
Children's, to provide the extra expertise that they need to be able to
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do this. So pediatric hospice care, it's just really small, and so there
are relatively few pediatric programs. Trinity Health in Los Angeles
is a great example of one that's been very successful. The
Steppingstones Program here in Seattle is the one that I mentioned,
is 15 years old now and is really quite successful, but it really took
a visionary person to make it happen.
[00:40:55]
Bryan Sisk:

Ross Hays:

[00:42:54]
Bryan Sisk:

Ross Hays:

How has interactions been between hospital-based programs,
especially in pediatrics, and the community-based programs?
I think in my observation good, generally. We share a mutual need,
which is the best interest of our patients. Palliative care programs
within hospitals are anxious for children to be able to spend their
final days in the setting that's most appropriate for them and for
many of them that's home. And so, it's our responsibility to allow
them to have that experience. We have a vested interest in getting
those children out of the hospital and home where they want to be
and to have them cared for appropriately once they get there. So we
have a strong interest in promoting community-based programs.
And the community-based programs, at least in my state, are
mandated to take children. The Certificate of Need for Hospice in
the State of Washington includes a clause that says that, "There
could be no discrimination based on age." So that means a hospice
that takes 99% older adults is required to take a pediatric patient if
it's referred in their catchment area. So they often look to us for
support and help in how to manage these kids. I think the we
mutually depend on each and our shared goal is to try to create the
best outcome for our patients and their families.
Looking over your career from the late-70s to date, what do you
think have been the biggest changes in care that we provide to these
kids that are suffering and dying?
[laughs] Wow. Well I think that the fact that we do have pediatric
palliative—well, between the 1970s and now, the fact that we have
pediatric palliative care at all. It did not exist obviously, when I
started my training or even when I stared as an attending physician.
So the biggest change is that we have this specialty with all of the
expertise and experience and authority and education that it has. The
answer to your question would be simple. We have this specialty that
makes a difference. To dive in a little deeper, I think that children
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die differently now than they did in the 70s. I think back then,
children would often die in the hospital, it was pretty rare for them
to die at home. I think we had less ability to prognosticate and to
plan for end-of-life care. I'll just give you an example that came up
recently.
In the late-70s when a child was born with hypoplastic left heart
syndrome, which is a fatal congenital cardiac condition, the babies
would be born, they would be okay for a few hours and then they'd
start getting sick. There would be some kind of emergency work up.
You would realize, "Oh my gosh, this baby has only one ventricle."
And you would gather up the family and say, "Oh, we're so sorry
there's nothing we can do." And the baby would live for a day or so.
And that was hypoplastic left heart. Well now in 2019, number one,
those children are diagnosed at 20 weeks gestation. They're
diagnosed long before they're born, and then there's an opportunity
to plan for their delivery. They're delivered in a high-risk center and
then there are a series of three very complicated surgeries available
to the family. So the family can be counseled, "Yes your baby is
going to have rough road ahead, but it's certainly not going to be
fatal, and the likelihood is your child is going to live, and maybe live
through these three surgeries and maybe on to have a heart transplant
and end up in college and beyond." So there are those kinds of
developments that create an entire need for palliative care.
I mean if you define palliative care broadly, which includes multidisciplinary supported continuity of care throughout the trajectory
of the illness and assisted decision making, than pediatric palliative
care for that child with hypoplastic left heart begins about five
months before that baby is born and then continues on through all
of those different phases of treatment. It's an entirely different
ballgame. Now again, back in the 70s, if you were treated for acute
lymphoblastic leukemia and then you relapsed, often you'd die. Now
if you’re treated and you relapse, then you go on to a more intensive
chemo therapy regimen. And then if you relapse again you go on to
bone marrow transplant. And then if that fails, then you usually have
a second bone marrow transplant. And if that fails then you're
referred on to CAR [Chimeric Antigen Receptor] T-Cell therapy.
And so these diseases that were once quite short and fatal are now
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prolonged and variably successful and so they create and entire need
for palliative care along the way. So lots of changes.
[00:48:00]
Bryan Sisk:

Ross Hays:

[00:49:05]
Bryan Sisk:

Ross Hays:

[00:51:18]

Looking at your career what is your favorite contribution to this field
that you've made?
[laughs] Survival? Maybe survival would that be it? The thing that
is most gratifying is that when I started, it was just kind of an uphill
struggle. You knew you were doing the right thing but half the time
you really had to devote your energy to convincing somebody else
that it was the right thing. I don't really feel like we face that
anymore. Now, we have a new generation of bright, young, welltrained physicians who want to this work and they're not having to
blaze the trail anymore. I think the pathway is already there, they
just now really get to do the work, which I think is a great thing.
What do you think are the biggest challenges that still face the field
right now?
Well we're in a medical economic system that doesn't value what we
do. And you can say that about all kinds of different aspects of health
care, we don't get paid for what we do. I always say if we could
provide palliative care consultation and colonoscopy, then we'd be
great because we would have a well-compensated procedure and
then we would never have to worry about money. But palliative care
programs, they add value but they don't generate revenue in our
system, and so they are variably precarious. I'm fortunate here at
Seattle Children's, we have a very generous hospital that recognizes
the value of what we do, and the fact that we don't bring in enough
money to offset our expenses has never been limitation or hasn't
been a big limitation, and you work with adjusting. At St. Jude it's
similar. They have the economic wherewithal to support this, but it's
not true everywhere and there are other programs that really are
struggling and are very precarious because their administration
doesn't recognize the value and they don't have the resources to
essentially support a loss leader. And so I think that in our present
system, the biggest barrier or the biggest threat or the biggest
challenge is to have a robust reimbursement system that supports
this everywhere, not just at wealthy children's hospitals like at St.
Jude's that can pay for almost anything.
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Bryan Sisk:

Looking at the whole field again, in what areas do you think the field
is the strongest?

Ross Hays:

I think it's the strongest in the commitment of this young generation
physicians who are doing the work. For over 10 years I was the only
palliative care doc here. Now there are eight at Seattle Children's,
and the other seven are all a generation younger than I am. And
they're well trained and they are interested in making a contribution
and they're getting additional training in methodology and research
experimental designs, statistical analysis so that they can improve
the value of what we do. And so I think this generation is by far the
best thing that can happen to pediatric palliative care.

[00:52:16]
Bryan Sisk:

Ross Hays:

And then the last question, I would really love you to dream aloud.
So if budget, politics, reimbursement and all the other things that we
talked about weren't an obstacle, what would you want care for these
children to look like in another 10 years?
I think I want it to be a seamlessly integrated system where pediatric
palliative care is recognized as one part of every bone marrow
transplant, one part of every complex congenital heart disease, one
part of the care for all children with leukemia at relapse, so that you
really don't require consultation anymore, you are just part of the
team. We don't apologize for the fact that we have a dietitian on the
leukemia team, that's just assumed that that's normal. We don't
apologize for the fact that we have a physical therapist on the cancer
care unit or that we have a social worker attached to the brain tumor
unit. We don't apologize for those things because we've all
recognized they are a necessary part of the team, that they have a
role to play, and they really don't require any justification anymore.
In my ideal world, pediatric palliative care, we have that same status.
I really think I’m not exaggerating when I say that after 20 years at
Seattle Children's we're pretty close to that. We're just integrated into
the care these high risk groups, we have an automatic seat at the
table for all the high risk leukemia admissions, we are consulted for
every bone marrow transplant. We are automatically consulted when
we have a child that goes on ECMO [Extracorporeal membrane
oxygenation]. I think, at least at our place, we're close to realizing
that goal, but I don't think that's true everywhere. The ideal state
would be where pediatric palliative care is recognized as a necessary
treatment for any child who has potential life limiting illness. It
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doesn't require consultation, it doesn't require justification, doesn't
require anything. We're just part of the game.
[00:54:53]
Bryan Sisk:

Ross Hays:

Those were all of the questions I have, but is there any area of this
history that you think that I should dig into deeper in the future?
I don't think so. I'm going to be really interested to see what you
come up with because I suspect that you're getting different stories
from people at different places, which I think should be quite
interesting.
[End of Audio]

